Lopinavir is an antiretroviral protease inhibitor used in combination with other antiretrovirals in the treatment of HIV-1 infection. Lopinavir is marketed and administered exclusively in combination with ritonavir - this combination, first marketed by Abbott under the brand name Kaletra in 2000, is necessary due to lopinavir's poor oral bioavailability and ...
用于高效抗逆转录病毒疗法(HAART)的组成药物。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.